Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer.

Manz, Salomon M; Losa, Marco; Fritsch, Ralph; Scharl, Michael

Manz, Salomon M; Losa, Marco; Fritsch, Ralph; Scharl, Michael.

Afiliación

Manz SM; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Losa M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Fritsch R; Center for Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Scharl M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Raemistrasse 100, Zurich, CH-8091, Switzerland.

Therap Adv Gastroenterol ; 14: 17562848211002018, 2021.

Article en En | MEDLINE | ID: mdl-33948110

Palabras clave

colorectal carcinoma (CRC); efficacy; immune checkpoint inhibitors (ICIs); side and adverse effects

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Therap Adv Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google